glp 1 drugs tirzepatide Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 among patients with type 2 diabetes, a large retrospective cohort Semaglutide & Tirzepatide Weight Loss
Description
Psychological aspects of switching receive less attention than physical effects but significantly impact experiences
.webp)
The drug will likely become pricier via self-pay as doses increase, though Novo Nordisk hasn't disclosed those prices yet
J Alzheimers Dis (2017) 60(3):85966
End Use Insights The hospitals segment held the largest market share in 2025
The injectable segment held the largest market share in 2024, supported by the early introduction and widespread use of injectable formulations such as liraglutide, semaglutide, and tirzepatide
Both are sold by Danish drug giant Novo Nordisk
